BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(2): 318-321 [PMID: 18186575 DOI: 10.3748/wjg.14.318]
URL: https://www.wjgnet.com/1007-9327/full/v14/i2/318.htm
Number Citing Articles
1
Kathryn R. Moss, Taylor S. Bopp, Anna E. Johnson, Ahmet Höke. New evidence for secondary axonal degeneration in demyelinating neuropathiesNeuroscience Letters 2021; 744: 135595 doi: 10.1016/j.neulet.2020.135595
2
Howard Chen. Muscle Channel Technique for Peripheral Sensory NeuropathyMedical Acupuncture 2010; 22(1): 57 doi: 10.1089/acu.2009.0714
3
Kensuke Shiga, Eijiroh Tanaka, Reina Isayama, Toshiki Mizuno, Kyoko Itoh, Masanori Nakagawa. Chronic Inflammatory Demyelinating Polyneuropathy Due to the Administration of Pegylated Interferon .ALPHA.-2b: A Neuropathology Case ReportInternal Medicine 2012; 51(2): 217 doi: 10.2169/internalmedicine.51.6320
4
Isaak Quast, Flavio Cueni, Falk Nimmerjahn, Björn Tackenberg, Jan D. Lünemann. Deregulated Fcγ receptor expression in patients with CIDPNeurology Neuroimmunology & Neuroinflammation 2015; 2(5) doi: 10.1212/NXI.0000000000000148
5
Mumtaz A Niazi, Ashaur Azhar, Kashif Tufail, Eyob L Feyssa, Stephen F Penny, Marlene McGregory, Victor Araya, Jorge A Ortiz. Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case reportWorld Journal of Hepatology 2010; 2(4): 162-166 doi: 10.4254/wjh.v2.i4.162
6
Viola Guardigni, Gabriele Fabbri, Anastasio Grilli, Carlo Contini. Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reportsAnnals of Hepatology 2012; 11(3): 404 doi: 10.1016/S1665-2681(19)30939-1
7
Jee-Eun Kim, Jae-Hyeok Heo, Hye-ok Kim, Sook-hee Song, Sang-Soon Park, Tai-Hwan Park, Jin-Young Ahn, Min-Ky Kim, Jae-Phil Choi. Neurological Complications during Treatment of Middle East Respiratory SyndromeJournal of Clinical Neurology 2017; 13(3): 227 doi: 10.3988/jcn.2017.13.3.227
8
Joerg-Patrick Stübgen. Interferon alpha and neuromuscular disordersJournal of Neuroimmunology 2009; 207(1-2): 3 doi: 10.1016/j.jneuroim.2008.12.008
9
Keiko Toyooka, Harutoshi Fujimura. Iatrogenic neuropathiesCurrent Opinion in Neurology 2009; 22(5): 475 doi: 10.1097/WCO.0b013e32832fbc52
10
Richard AC Hughes, Jane Pritchard, Robert DM Hadden, Richard AC Hughes. Cochrane Database of Systematic Reviews2013;  doi: 10.1002/14651858.CD008630.pub3
11
Luis del Carpio Orantes. Síndrome de Guillain y Barré variedad Miller Fisher asociado a hepatitis viral BNeurología Argentina 2019; 11(1): 40 doi: 10.1016/j.neuarg.2018.01.003
12
Kazuaki Nishio, Takeshi Konndo, Shunichi Okada, Machiko Enchi. Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis CWorld Journal of Hepatology 2010; 2(9): 358-361 doi: 10.4254/wjh.v2.i9.358
13
Monica Cesarini, Erika Angelucci, Tiziana Foglietta, Piero Vernia. Guillain–Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: Case report and literature reviewJournal of Crohn's and Colitis 2011; 5(6): 619 doi: 10.1016/j.crohns.2011.06.010
14
Richard AC Hughes, Jane Pritchard, Robert DM Hadden, Richard AC Hughes. Cochrane Database of Systematic Reviews2011;  doi: 10.1002/14651858.CD008630.pub2
15
Jonathan P. Congeni, Robert B. Kirkpatrick. Pegylated Interferon Induced Myasthenia Crisis—A Case ReportJournal of Clinical Neuromuscular Disease 2013; 14(3): 123 doi: 10.1097/CND.0b013e318285257f
16
Jane Pritchard, Richard AC Hughes, Robert DM Hadden, Ruth Brassington. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndromeCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD008630.pub4
17
Alexandre Chlilek, Claire Roger, Laurent Muller, Marie-Josée Carles, Robin Stephan, Didier Laureillard, Jean-Philippe Lavigne, Jean-Yves Lefrant, Albert Sotto. Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case reportBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4278-7
18
Fatime Nilüfer Yalçindağ, Cem Alay. Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitisF1000Research 2013; 2: 245 doi: 10.12688/f1000research.2-245.v1
19
Bil Randerson Bassetti, Eduardo Sturzeneker Trés, Jovana Gobbi Marchesi Ciríaco, Lauro Ferreira Silva Pinto Neto. Polineuropatia desmielinizante inflamatória crônica pós-tratamento com interferon peguilado alfa 2b em um paciente co-infectado HIV/HCV: relato de casoRevista da Sociedade Brasileira de Medicina Tropical 2010; 43(1): 89 doi: 10.1590/S0037-86822010000100019
20
Johann Sellner, Israel Steiner. NeurovirologyHandbook of Clinical Neurology 2014; 123: 647 doi: 10.1016/B978-0-444-53488-0.00031-6
21
Joerg-Patrick Stübgen. Drug-induced dysimmune demyelinating neuropathiesJournal of the Neurological Sciences 2011; 307(1-2): 1 doi: 10.1016/j.jns.2011.05.010
22
Benjamin R Wakerley, Nobuhiro Yuki. Infectious and noninfectious triggers in Guillain–Barré syndromeExpert Review of Clinical Immunology 2013; 9(7): 627 doi: 10.1586/1744666X.2013.811119
23
Sergio Ferrari, Sara Mariotto, Tiziana Cavallaro, Gianmaria Fabrizi, Salvatore Monaco. Acquired Neuromuscular Disorders2016; : 261 doi: 10.1007/978-3-319-29514-5_19
24
Kato Verstrepen, Laure Baisier, Harald De Cauwer. Neurological manifestations of COVID-19, SARS and MERSActa Neurologica Belgica 2020; 120(5): 1051 doi: 10.1007/s13760-020-01412-4
25
Sergio Ferrari, Sara Mariotto, Tiziana Cavallaro, Gian Maria Fabrizi, Salvatore Monaco. Acquired Neuromuscular Disorders2022; : 343 doi: 10.1007/978-3-031-06731-0_19